By restoring more normal insulin signaling, GLP-1 medications help normalize immune tolerance and reduce the hyperactive T-cell responses characteristic of psoriatic disease
Lifestyle still matters diet, exercise, and targeted supplements amplify results
However, retatrutide remains an investigational medicinal product and, as of mid-2025, has not been approved for clinical use in the United Kingdom or elsewhere
KEGG pathway- mmu04550: 1: Liu X, Nefzger CM, Rossello FJ, Chen J, Knaupp AS, Firas J, Ford E, Pflueger J, Paynter JM, Chy HS, O'Brien CM, Huang C, Mishra K, Hodgson-Garms M, Jansz N, Williams SM, Blewitt ME, Nilsson SK, Schittenhelm RB, Laslett AL, Lister R, Polo JM
The most significant safety concern is an FDA boxed warning for a potential risk of medullary thyroid carcinoma (MTC)
Improves Skin: Some people say it helps skin look brighter and healthier